Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators. 1998

T A Grese, and L D Pennington, and J P Sluka, and M D Adrian, and H W Cole, and T R Fuson, and D E Magee, and D L Phillips, and E R Rowley, and P K Shetler, and L L Short, and M Venugopalan, and N N Yang, and M Sato, and A L Glasebrook, and H U Bryant
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA.

The 2-arylbenzothiophene raloxifene, 1, is a selective estrogen receptor modulator (SERM) which is currently under clinical evaluation for the prevention and treatment of postmenopausal osteoporosis. In vivo structure-activity relationships and molecular modeling studies have indicated that the orientation of the basic amine-containing side chain of 1, relative to the stilbene plane, is an important discriminating factor for the maintenance of tissue selectivity. We have constructed a series of analogues of 1 in which this side chain is held in an orientation which is orthogonal to the stilbene plane, similar to the low-energy conformation predicted for raloxifene. Herein, we report on the synthesis of these compounds and on their activity in a series of in vitro and in vivo biological assays reflective of the SERM profile. In particular, we describe their ability to (1) bind the estrogen receptor, (2) antagonize estrogen-stimulated proliferation of MCF-7 cells in vitro, (3) stimulate TGF-beta3 gene expression in cell culture, (4) inhibit the uterine effects of ethynyl estradiol in immature rats, and (5) potently reduce serum cholesterol and protect against osteopenia in ovariectomized (OVX) rats without estrogen-like stimulation of uterine tissue. These data demonstrate that one of these compounds, LY357489,4, is among the most potent SERMs described to date with in vivo efficacy on bone and cholesterol metabolism in OVX rats at doses as low as 0.01 mg/kg/d.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009285 Naphthoquinones Naphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups. Naphthalenediones,Naphthazarins,Naphthoquinone
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D010052 Ovariectomy The surgical removal of one or both ovaries. Castration, Female,Oophorectomy,Bilateral Ovariectomy,Bilateral Ovariectomies,Castrations, Female,Female Castration,Female Castrations,Oophorectomies,Ovariectomies,Ovariectomies, Bilateral,Ovariectomy, Bilateral
D010880 Piperidines A family of hexahydropyridines.
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D004965 Estrogen Antagonists Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. Estradiol Antagonists,Antagonists, Estradiol,Antagonists, Estrogen

Related Publications

T A Grese, and L D Pennington, and J P Sluka, and M D Adrian, and H W Cole, and T R Fuson, and D E Magee, and D L Phillips, and E R Rowley, and P K Shetler, and L L Short, and M Venugopalan, and N N Yang, and M Sato, and A L Glasebrook, and H U Bryant
January 1999, Medicine and health, Rhode Island,
T A Grese, and L D Pennington, and J P Sluka, and M D Adrian, and H W Cole, and T R Fuson, and D E Magee, and D L Phillips, and E R Rowley, and P K Shetler, and L L Short, and M Venugopalan, and N N Yang, and M Sato, and A L Glasebrook, and H U Bryant
January 2005, Journal of medicinal chemistry,
T A Grese, and L D Pennington, and J P Sluka, and M D Adrian, and H W Cole, and T R Fuson, and D E Magee, and D L Phillips, and E R Rowley, and P K Shetler, and L L Short, and M Venugopalan, and N N Yang, and M Sato, and A L Glasebrook, and H U Bryant
June 2005, Organic letters,
T A Grese, and L D Pennington, and J P Sluka, and M D Adrian, and H W Cole, and T R Fuson, and D E Magee, and D L Phillips, and E R Rowley, and P K Shetler, and L L Short, and M Venugopalan, and N N Yang, and M Sato, and A L Glasebrook, and H U Bryant
October 1992, Journal of medicinal chemistry,
T A Grese, and L D Pennington, and J P Sluka, and M D Adrian, and H W Cole, and T R Fuson, and D E Magee, and D L Phillips, and E R Rowley, and P K Shetler, and L L Short, and M Venugopalan, and N N Yang, and M Sato, and A L Glasebrook, and H U Bryant
May 1999, Drugs & aging,
T A Grese, and L D Pennington, and J P Sluka, and M D Adrian, and H W Cole, and T R Fuson, and D E Magee, and D L Phillips, and E R Rowley, and P K Shetler, and L L Short, and M Venugopalan, and N N Yang, and M Sato, and A L Glasebrook, and H U Bryant
June 2009, Climacteric : the journal of the International Menopause Society,
T A Grese, and L D Pennington, and J P Sluka, and M D Adrian, and H W Cole, and T R Fuson, and D E Magee, and D L Phillips, and E R Rowley, and P K Shetler, and L L Short, and M Venugopalan, and N N Yang, and M Sato, and A L Glasebrook, and H U Bryant
September 2007, Steroids,
T A Grese, and L D Pennington, and J P Sluka, and M D Adrian, and H W Cole, and T R Fuson, and D E Magee, and D L Phillips, and E R Rowley, and P K Shetler, and L L Short, and M Venugopalan, and N N Yang, and M Sato, and A L Glasebrook, and H U Bryant
January 2001, Reproduction, fertility, and development,
T A Grese, and L D Pennington, and J P Sluka, and M D Adrian, and H W Cole, and T R Fuson, and D E Magee, and D L Phillips, and E R Rowley, and P K Shetler, and L L Short, and M Venugopalan, and N N Yang, and M Sato, and A L Glasebrook, and H U Bryant
April 1977, Journal of medicinal chemistry,
T A Grese, and L D Pennington, and J P Sluka, and M D Adrian, and H W Cole, and T R Fuson, and D E Magee, and D L Phillips, and E R Rowley, and P K Shetler, and L L Short, and M Venugopalan, and N N Yang, and M Sato, and A L Glasebrook, and H U Bryant
April 2004, Journal of medicinal chemistry,
Copied contents to your clipboard!